JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
MGX - Metagenomi Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary MGX Stock
Financials
Financials MGX Stock
Loading...
Loading...
Income Statement
Income Statement MGX Stock
Balance Sheet
Balance Sheet MGX Stock
Cash Flow Statement
Cash Flow Statement MGX Stock
Loading...
Loading...
MGX Financials - Metagenomi Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Metagenomi Therapeutics, Inc. (MGX)
Financials
Financials of MGX
Loading...
Loading...
Loading...
Loading...
Revenue
$25.21M
Operating Income
$-96.013M
Net Income
$-87.868M
Share Count (Basic)
37.25105M
Operating Cash Flow
$-88.892M
Free Cash Flow
$-89.466M
Cash And Short-Term Equivalents
$41.722M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
10M
20M
30M
40M
50M
FY2023
FY2024
FY2025
Revenue $USD
0
2M
4M
6M
8M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-85M
-80M
-75M
-70M
FY2023
FY2024
Annual
Quarterly
Margins
Gross
Operating
Net
-400%
-350%
-300%
-250%
-200%
-150%
FY2025
Net Income $USD
-24M
-22M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-2000%
-1500%
-1000%
-500%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26